FindTrial
Sign In

EFFECT OF MECHANICAL BOWEL PREPARATION WITH POLYETHYLENE GLYCOL PLUS BOWEL ENEMA (GLYCERIN 5%) VS BOWEL ENEMA ALONE IN PATIENTS CANDIDATES TO COLORECTAL RESECTION FOR MALIGNANCY. PROSPECTIVE RANDOMIZED CLINICAL TRIAL - ND

EFFECT OF MECHANICAL BOWEL PREPARATION WITH POLYETHYLENE GLYCOL PLUS BOWEL ENEMA (GLYCERIN 5%) VS BOWEL ENEMA ALONE IN PATIENTS CANDIDATES TO COLORECTAL RESECTION FOR MALIGNANCY. PROSPECTIVE RANDOMIZED CLINICAL TRIAL - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-003309-28-IT
Enrollment
Unknown
Registered
2007-07-30
Start date
2007-10-01
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colo-rectal cancer MedDRA version: 6.1 Level: PT Classification code 10061451

Interventions

Trade Name: ISOCOLAN*8BUST 34,8G S/CONTENI Pharmaceutical Form: Oral powder CAS Number: 7757-82-6 Concentration unit: % percent Concentration type: equal Concentration number: 34.8- CAS Number: 144-55

Sponsors

ISTITUTO EUROPEO DI ONCOLOGIA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with colon rectal carcinoma undergoing surgical resection with curative intent. Age 18-80 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: patients with high probability for colon-ileo derivation ; patients with bowel stenosis; patients with bowel occlusion

Design outcomes

Primary

MeasureTime frame
Main Objective: INCIDENCE OF POST OPERATIVE COMPLICATIONS;Secondary Objective: QUALITY OF LIFE - DURATION OF HOSPITAL STAY;Primary end point(s): post operative complications—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026